ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,019.51
      0.11%
      US Tech 100
      20,972.00
      -0.34%
      Dow Jones
      43,599.13
      0.39%
      Brent Oil
      74.355
      0.34%
      Bitcoin
      94,781.22
      -1.55%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Halozyme Therapeutics Inc (0J2O) Quote

      Halozyme Therapeutics Inc

      Halozyme Therapeutics Inc (0J2O)

      LSE
      18.26
      0.00
      (0.00%)
      Closed February 24 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      18.26
      Bid
      0.00
      Ask
      0.00
      Volume
      77
      0.00 Day's Range 0.00
      18.26 52 Week Range 18.26
      Market Cap
      2.412B
      Previous Close
      18.26
      Open
      -
      Last Trade
      8
      @
      58.406
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,390
      Shares Outstanding
      132,098,000
      Dividend Yield
      -
      PE Ratio
      27.34
      Earnings Per Share (EPS)
      2.13
      Revenue
      829.25M
      Net Profit
      281.59M

      About Halozyme Therapeutics Inc

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.halozyme.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Halozyme Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0J2O. The last closing price for Halozyme Therapeutics was $18.26. Over the last year, Halozyme Therapeutics shares have traded in a share price range of $ 18.26 to $ 18.26.

      Halozyme Therapeutics currently has 132,098,000 shares outstanding. The market capitalization of Halozyme Therapeutics is $2.41 billion. Halozyme Therapeutics has a price to earnings ratio (PE ratio) of 27.34.

      Ask ADVFN Intelligence (AI)

      0J2O Latest News

      More News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10018.2618.2618.2674418.26DE
      40018.2618.2618.2691418.26DE
      120018.2618.2618.26139018.26DE
      260018.2618.2618.26141618.26DE
      520018.2618.2618.26103818.26DE
      1560018.2618.2618.2667218.26DE
      2600018.2618.2618.2643718.26DE

      0J2O - Frequently Asked Questions (FAQ)

      What is the current Halozyme Therapeutics share price?
      The current share price of Halozyme Therapeutics is $ 18.26
      How many Halozyme Therapeutics shares are in issue?
      Halozyme Therapeutics has 132,098,000 shares in issue
      What is the market cap of Halozyme Therapeutics?
      The market capitalisation of Halozyme Therapeutics is USD 2.41B
      What is the 1 year trading range for Halozyme Therapeutics share price?
      Halozyme Therapeutics has traded in the range of $ 18.26 to $ 18.26 during the past year
      What is the PE ratio of Halozyme Therapeutics?
      The price to earnings ratio of Halozyme Therapeutics is 27.34
      What is the cash to sales ratio of Halozyme Therapeutics?
      The cash to sales ratio of Halozyme Therapeutics is 9.28
      What is the reporting currency for Halozyme Therapeutics?
      Halozyme Therapeutics reports financial results in USD
      What is the latest annual turnover for Halozyme Therapeutics?
      The latest annual turnover of Halozyme Therapeutics is USD 829.25M
      What is the latest annual profit for Halozyme Therapeutics?
      The latest annual profit of Halozyme Therapeutics is USD 281.59M
      What is the registered address of Halozyme Therapeutics?
      The registered address for Halozyme Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
      What is the Halozyme Therapeutics website address?
      The website address for Halozyme Therapeutics is www.halozyme.com
      Which industry sector does Halozyme Therapeutics operate in?
      Halozyme Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WG.Wood Group (john) Plc
      36.00p
      (36.36%)
      		70.89M
      PETPetrel Resources Plc
      1.90p
      (26.67%)
      		1.07M
      EPPEnergypathways Plc
      6.85p
      (22.32%)
      		13.06M
      CLACelsius Resources Limited
      0.61p
      (22.00%)
      		23.63M
      MET1Metals One Plc
      0.425p
      (21.43%)
      		1.05M
      GWMOGreat Western Mining Corporation Plc
      0.0105p
      (-30.00%)
      		187.73M
      SCGLSealand Capital Galaxy Limited
      1.75p
      (-20.45%)
      		25.8M
      SYNSynergia Energy Ltd
      0.0305p
      (-16.44%)
      		60.26M
      TLYTotally Plc
      3.10p
      (-15.07%)
      		16.79M
      NTQEnteq Technologies Plc
      2.05p
      (-14.58%)
      		1.5M
      SYMESupply@me Capital Plc
      0.004p
      (3.90%)
      		1.09B
      TRPTower Resources Plc
      0.0265p
      (-3.64%)
      		638.37M
      NTVONativo Resources Plc
      0.0015p
      (0.00%)
      		402.54M
      UKOGUk Oil & Gas Plc
      0.01175p
      (-2.08%)
      		289.61M
      GWMOGreat Western Mining Corporation Plc
      0.0105p
      (-30.00%)
      		187.73M

      Discussion

      View Full Feed
      flipper44 flipper44 41 seconds ago
      I’m seeing pink elephants dancing on the head of a needle by midweek. I can now confirm I’m seeing pink elephants dancing on the head of a pin by midweek.
      NWBO
      Mark Mark 47 seconds ago
      $PTPI & $ICON adding for swings. Will be adding dips as they come along
      ICON PTPI
      Longstrongsilver Longstrongsilver 58 seconds ago
      Since it said *could start as early as I took it to be none of us knows when starting for certain? For that we would have needed * will be starting on . Not being negative at all. Only realistic. Let’s hope it is March 3 and catches us completely off guard.
      AZRH
      AyaStocks AyaStocks 1 minute ago
      Market not catching up with fire news today. I think that once that news hits more scanners this will move back up out of support levels.

      $ADIA
      ADIA
      NotSure2 NotSure2 1 minute ago
      Dbing, is that prediction of your similar to your previous one?

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175457539
      NWBO
      TheKid5 TheKid5 1 minute ago
      Suspicious? Very perceptive. This whole thing is, but I still got myh money in!
      TPTW
      RealDutch RealDutch 1 minute ago
      I don't care about USDC. I know what my tokens are worth.

      $1 is a floor price, for tax purposes. Between $10 and $25 could be fair value until we get the earnings results. I don't expect it to go much higher than that, assuming we have 600M tokens outstanding.

      But first
      ITUP
      bobroo bobroo 1 minute ago
      Allow me to put it in simple English for you:

      There is no such thing— nor has there ever been— a MAZE.
      LQMT
      rainmaker71 rainmaker71 1 minute ago
      hummingbird...what do you say? will there be any news out this week?
      VDRM
      threewheeler threewheeler 1 minute ago
      well spreading the buying out, I'm sure is spend some as revenue increases, so the buy back money does not hamper growth in anyway, really smart
      AZRH
      prototype_101 prototype_101 1 minute ago
      Ha!! Too funny!! That’s some powerful new snake oil you’re are trying to peddle there teddybear!!
      So according to you I guess investors should believe that nothing has changed in the last handful of years to warrant anything higher than your “Historical market cap is around $50 million” right
      LWLG
      ElectricJester54 ElectricJester54 1 minute ago
      Ya I understand what you mean. I would guess that they are going to snag opportunities as strategically as possible so they wouldn't really be able to say we will buy X amount of shares on this date. I would guess they have a certain amount of money set aside and someone who will be wathcing for opp
      AZRH
      Filterthenoise Filterthenoise 1 minute ago
      MegaDumbAss FUD🎅
      RNVA
      fung_derf fung_derf 2 minutes ago
      Ahhhhh, it's springtime again, where all talk on this board roam to unimportant information only about NY teams.
      Who really cares if a yankee has a mustache or sings a different Frank Sinatra song?
      Can't this board stay baseball-centric?
      KILLAZILLA KILLAZILLA 2 minutes ago
      PATHETIC!!! 1M FOR $300...."TO MUCH TRADING"????? LOLOLOLOL
      INQD
      pos_stock_hoarder pos_stock_hoarder 2 minutes ago
      I'm not familiar with him. I'm assuming that's just as well. But he'll still be around. But Reid won't so that's awesome!
      thecrusher2011 thecrusher2011 2 minutes ago
      Your little Paul Krugman guy must be weeping in his pillow. His little narrative isn't working out the way he planned.


      https://investorshub.advfn.com/uimage/uploads/2025/2/24/dbcdwScreenshot_20250224-104346.png
      Homebrew Homebrew 2 minutes ago
      That's a lot of huffing and puffing over deleted posts on 1 board.
      muee88 muee88 2 minutes ago
      Ah yes, the classic 'I have no counterargument, so I'll just condescendingly pretend you used the term incorrectly' move. Nice strategy. Let me know when you’re ready to engage with reality instead of desperately flailing for a way to save face.
      NWBO
      getmenews getmenews 2 minutes ago
      https://investorshub.advfn.com/uimage/uploads/2025/2/24/cwyzo200_DMA_Buy_Alert.jpg
      XRPUSD
      BGCapital BGCapital 2 minutes ago
      AIBT closing on a $40M acquisition https://x.com/stockpicksnyc/status/1892265771809579493?s=46
      AIBT
      DiscoverGold DiscoverGold 2 minutes ago
      Fri’s Big Selloff Appears Before NVDA’s Earnings Results Due Wed, With Stock Suffering Rejection In Jan At Nov High
      By: Hedgopia | February 24, 2025

      • Last Friday’s sudden selloff in equities speaks of heightened investor nerves. Amidst this, NVDA, the poster child of the
      AAPL GOOG MSFT
      SkeBallLarry SkeBallLarry 3 minutes ago
      Lester Holt is stepping down as anchor of >

      'NBC Nightly News' after a decade >
      https://www.nbcnews.com/news/us-news/lester-holt-anchor-nbc-nightly-news-rcna193445
      TheKid5 TheKid5 3 minutes ago
      "barrage of news", Jeffy
      Dictrionary: bar·rage , /b?'rä(d)ZH/ , noun
      a concentrated artillery bombardment over a wide area.
      MRES
      Saving Grace Saving Grace 3 minutes ago
      LMC, now NU Ride Inc. NRDE, already had the prototype SUV before the Endurance and shelved the SUV EV production, making way for Endurance production. NU Ride Inc. still has the electric SUV and "car to build upon" as stated in filings.

      NU Ride Inc. with new ticker symbol is indeed a
      NRDE

      Your Recent History

      LSE
      0J2O
      Halozyme Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads